WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Stock Ownership - Who owns Fulcrum Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Fulcrum Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Greg TourangeauVice President Finance2024-03-084,884$11.72
$57.22kSell
Alex SapirPresident Chief Executive Officer2024-03-0443,360$11.35
$492.05kBuy
Greg TourangeauPrincipal Accounting Officer2023-05-10210$3.31
$695.10Sell

1 of 1

FULC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FULC insiders and whales buy or sell their stock.

FULC Shareholders

What type of owners hold Fulcrum Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP30.05%18,609,704$132.87MInsider
Ra Capital Management LP18.74%11,609,704$82.89MInstitution
Mark J. Levin9.76%6,046,425$43.17MInsider
Fmr LLC9.18%5,684,615$40.59MInstitution
Suvretta Capital Management LLC8.91%5,518,881$39.40MInstitution
Rtw Investments LP8.83%5,469,956$39.06MInstitution
Cowen And Company LLC5.61%3,473,934$24.80MInstitution
Vanguard Group Inc4.07%2,519,984$17.99MInstitution
Third Rock Ventures Iii LP4.04%2,499,343$17.85MInsider
Third Rock Ventures Iv LP3.78%2,343,154$16.73MInsider

1 of 3

FULC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FULC64.02%35.98%Net BuyingNet Buying
THRD73.29%26.71%Net BuyingNet Buying
OCS10.87%0.00%
TBPH60.28%39.72%Net SellingNet Selling
TSHA69.58%15.93%Net BuyingNet Selling
View Top Biotech Stocks

Fulcrum Therapeutics Stock Ownership FAQ

Who owns Fulcrum Therapeutics?

Fulcrum Therapeutics (NASDAQ: FULC) is owned by 98.63% institutional shareholders, 55.44% Fulcrum Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Fulcrum Therapeutics shareholder, owning 18.61M shares representing 30.05% of the company. Ra Capital Management LP's Fulcrum Therapeutics shares are currently valued at $132.87M.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.